HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer

Yasuyuki Kawamoto; Satoshi Yuki; Hideyuki Hayashi; Shintaro Nakano; Kentaro Sawada; Tetsuhito Muranaka; Hiroshi Nakatsumi; Takuro Saiki; Atsushi Ishiguro; Kazuaki Harada; Yoshimitsu Kobayashi; Ichiro Iwanaga; Kazuteru Hatanaka; Yuh Sakata; Naoya Sakamoto; Yoshito Komatsu

doi:10.1093/annonc/mdy374.051

HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer

Yasuyuki Kawamoto, Satoshi Yuki, Hideyuki Hayashi, Shintaro Nakano, Kentaro Sawada, Tetsuhito Muranaka, Hiroshi Nakatsumi, Takuro Saiki, Atsushi Ishiguro, Kazuaki Harada, Yoshimitsu Kobayashi, Ichiro Iwanaga, Kazuteru Hatanaka, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu

Oncology Center

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	vii63
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy374.051
Publication status	Published - 2018 Oct 1

ASJC Scopus subject areas

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdy374.051

Cite this

Kawamoto, Y., Yuki, S., Hayashi, H., Nakano, S., Sawada, K., Muranaka, T., Nakatsumi, H., Saiki, T., Ishiguro, A., Harada, K., Kobayashi, Y., Iwanaga, I., Hatanaka, K., Sakata, Y., Sakamoto, N., & Komatsu, Y. (2018). HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 29, vii63. https://doi.org/10.1093/annonc/mdy374.051

Kawamoto, Y, Yuki, S, Hayashi, H, Nakano, S, Sawada, K, Muranaka, T, Nakatsumi, H, Saiki, T, Ishiguro, A, Harada, K, Kobayashi, Y, Iwanaga, I, Hatanaka, K, Sakata, Y, Sakamoto, N & Komatsu, Y 2018, 'HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. vii63. https://doi.org/10.1093/annonc/mdy374.051

@article{1b35d179f61349d6adbc0d8a658d2394,

title = "HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer",

author = "Yasuyuki Kawamoto and Satoshi Yuki and Hideyuki Hayashi and Shintaro Nakano and Kentaro Sawada and Tetsuhito Muranaka and Hiroshi Nakatsumi and Takuro Saiki and Atsushi Ishiguro and Kazuaki Harada and Yoshimitsu Kobayashi and Ichiro Iwanaga and Kazuteru Hatanaka and Yuh Sakata and Naoya Sakamoto and Yoshito Komatsu",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy374.051",

language = "English",

volume = "29",

pages = "vii63",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - HGCSG 1403

T2 - phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer

AU - Kawamoto, Yasuyuki

AU - Yuki, Satoshi

AU - Hayashi, Hideyuki

AU - Nakano, Shintaro

AU - Sawada, Kentaro

AU - Muranaka, Tetsuhito

AU - Nakatsumi, Hiroshi

AU - Saiki, Takuro

AU - Ishiguro, Atsushi

AU - Harada, Kazuaki

AU - Kobayashi, Yoshimitsu

AU - Iwanaga, Ichiro

AU - Hatanaka, Kazuteru

AU - Sakata, Yuh

AU - Sakamoto, Naoya

AU - Komatsu, Yoshito

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85082003252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082003252&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy374.051

DO - 10.1093/annonc/mdy374.051

M3 - Article

C2 - 32177472

AN - SCOPUS:85082003252

SN - 0923-7534

VL - 29

SP - vii63

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this